Navigation Links
Tainted Chinese Food Ingredients First Discovered in 2005

Wide-spread ingredient quality concerns forced TSI Health Sciences to

change direction.

MISSOULA, Mont., Aug. 20 /PRNewswire-USNewswire/ -- In 2005, TSI Health Sciences, a well-respected $50 million dietary supplement industry ingredients supplier based in Missoula, Montana, then known as Technical Sourcing International, was drawn into a wide-spread quality issue with the company's primary Chinese manufacturers. One of their top selling ingredients, chondroitin (sulfate), a popular osteoarthritis ingredient used today by millions of Americans to treat joint pain and stiffness, was deliberately adulterated with a chemical that TSI chemists could not even identify.

"Our Chinese suppliers were profiting by tricking our testing techniques," said Joe Zhou, president of TSI international operations responsible for corporate business development.

"Ingredient samples tested positive for chondroitin, but it wasn't chondroitin," said Larry Kolb, president of TSI US operations. "We caught several producers of our chondroitin ingredient red handed," notes Kolb.

Nine years earlier in Michigan, Zhou, a research chemist at Amway Corp., and Kolb, vice president for Charles Bowman & Company directing ingredient sales and marketing strategies for the company's personal care, OTC and dietary supplement industries customers, pooled their resources and invested $2,000 to start an ingredient business that, as Kolb recalls, "would bring the best ingredients to the US from China."

They worked on their business model for seven years envisioning the opportunity to perform a service that would assure the overall quality and safety of Chinese ingredients for US supplement manufacturers. "We gave customers the best of all worlds -- Chinese prices and US quality," says Kolb.

Kolb remembers the product testing incident like it was yesterday. They had critical and extremely difficult decisions on their hands. How do they control production of their top selling product and more importantly, the survival of their business?

Kolb and Zhou zigzagged across the US faced with the tough task of meeting with their customers as well as nervous investors to advise them of the crisis. As a result of those meetings, they decided to change the direction of the company to personally ensure safe, quality ingredients for their customers. "Our customers told us to do the right thing, so we did," Kolb said.

TSI moved forward with building a 60-acre complex near Shanghai that stands as an exemplary manufacturing model with Quality Control and Quality Assurance laboratories to produce premier ingredients including the highest potency chondroitin sulfate in the world. Moving from a stocking distributor to a fully integrated pharmaceutical manufacturer, the company now sells chondroitin to drug and quality oriented supplements companies, primarily in Japan and Europe as their customer base continues to grow in other markets including Australia.

The move ultimately didn't play out well with the majority of TSI's US customers. "What concerns me now is not all of our customers moved in the same direction to purchase quality ingredients," added Kolb. Since then, TSI has lost more than 70% of its US revenues from the dietary supplement industry.

One company that did move in the right direction was Pharmavite, a manufacturer that sells $600 million of Nature Made brand supplements in the US alone. Pharmavite has worked on a project for the past three years that has involved a TSI shark chondroitin ingredient.

"We had to find a special type of chondroitin for our Nature Made Japan products that met our regulatory needs," said Doug Roper, director of quality development for Pharmavite international group.

TSI, like Pharmavite, is part of a dietary ingredient verification program headed by the United States Pharmacopeia, the official public standards- setting authority for all prescription and over-the-counter medicines, dietary supplements, and other healthcare products manufactured and sold in over 130 countries, including the United States. "They audited and evaluated TSI's materials to certify them in their program," said Roper. "This gave us the assurance that TSI ingredients were not contaminated and met US requirements." Roper also visited the TSI China facility and continues to do so to further ensure quality manufacturing.

"A recent recall of shark cartilage capsules at the retail level in the US found salmonella contamination," says Roper. "The manufacturer was probably buying material from a Chinese supplier who didn't test for salmonella. TSI tests for salmonella and provides Pharmavite with proper certification," added Roper. "We know we selected the right supplier for our products."

"Regrettably, companies within the US supplement market were not willing to move up the supply chain when the unhealthy manufacturing realities of many Chinese companies was first revealed," stated Kolb. "TSI has remained steadfast to its commitment to providing safe ingredients to the marketplace and accepted the challenge to do things right," says Kolb. Since 2005, the issues surrounding low quality products produced in China persist as a reflection of the recent melamine crisis involving pet food.

According to Loren Israelsen, executive director of the United Natural Products Alliance, a trade organization representing many of the world's leading dietary supplement companies, the questions about Chinese products are probably the most important issues facing the supplement industry today. China is such a significant supplier of raw materials, partially finished and finished products to the US supplement industry. "But the uncertainty of quality materials is actually a global concern," says Israelsen.

"There are many world-class, ethical companies in China such as TSI, as well as in other countries; it's just there are more companies in China, both good and bad, and the good aren't often recognized for what they bring to the US consumer," said Israelsen. "China will have to get tougher within its government system and business infrastructure."

Kolb and Zhou aren't throwing in the towel in the US marketplace. TSI expects 2007 to be a watershed year for new regulations in the food ingredient area. "It's good the ingredient crisis is in the news. I'm sure this will force change that will benefit the dietary supplement industry and the good guys doing business in that industry," notes Kolb.

"We think the day will come when the US government, particularly the Food and Drug Administration (FDA), has the means and measures to monitor and watch the quality of food ingredients coming into the US," said Kolb.

"I've worked with the FDA for over 30 years," says Roper. "They're under-funded and lack sufficient staff. Other than increased surveillance I'm not sure what they'll do. The US public demands safety, so it's up to each manufacturer to ensure their products are safe, no matter what the cost," adds Roper.

According to Kolb, TSI is following their new plan with the promise that they will continue to bring the best ingredients to all of their customers willing to step up to the plate by purchasing quality products. Over the past 11 years, TSI Health Sciences has emerged as one of the up-and-coming international ingredient manufacturers. The company was recently recognized by the Nutrition Business Journal, an industry watch dog, with the 'Investment for the Future' award and Nutraceuticals World, a leading nutraceutical industry trade magazine, selected TSI in June as a 'company to watch' in ingredient manufacturing, quality and innovations.

"As ingredient manufacturers we are the front line defense to protect the health and well being of the consumer. As serious doubts and concerns surrounding Chinese products continue in the US market, TSI stands ready as a reliable partner for companies seeking guaranteed safe ingredients for their product formulations," says Kolb.

SOURCE TSI Health Sciences

Copyright©2007 PR Newswire.

Related medicine technology :

1. Investigation Findings, Corroborated by Empirical Evidence of the Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine for Hundreds of Years, Support the Use of Schisandrin B in the Prevention and Treatment of IHD
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
5. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
6. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
7. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
8. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
9. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
10. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
11. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
Post Your Comments:
(Date:12/7/2016)... Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ... present a company overview at the BMO Capital Markets Prescriptions for ... York, NY . A live webcast of the ... the Ionis website.  The replay will be available within 48 hours ... ...
(Date:12/7/2016)... 7, 2016 Today, presents four ... JAZZ ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ... AveXis Inc. (NASDAQ: AVXS ). From its peak ... 37% to reach a level equal to what it saw ... approximately 14% for the year, it has still out-performed other ...
(Date:12/7/2016)... According to the latest market ... Study on Multiplex Detection Immunoassay: North America to Dominate ... detection immunoassay market is expected to witness a CAGR of ... ...      (Logo: ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., ... Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience ... to help patients realize their family building goals. Acupuncture helps fertility patients ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Fred Rides a Train” allows readers to ... , “Fred Rides a Train” is the creation of published author, Janet Morrison, ... teen years in Michigan. The "Fred, the Dog" series is her first attempt at ...
(Date:12/7/2016)... ... December 07, 2016 , ... NuevaCare, a leading home care agency ... to announce new city-specific pages as part of its ambitious website relaunch. As Bay ... look, first, for local agencies serving their city. The new site has several key ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum ... risk of serious health problems, such as cardiovascular illness, according to research cited ... Beverly Hills Periodontics & Dental Implant Center notes that the correlation between periodontal ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... has named Ajdin Camaga as a vice president of sales. , “Ajdin understands ... president. “He works hard to understand what each client needs, and is persistent ...
Breaking Medicine News(10 mins):